Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto
CA 1339952 C · Owner: Bayer Corporation · Inventors: Haigh, Wallace; Marchesi, Vincent T.; Knowles, William J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Binding of a particular protein by an antibody reagent involving denaturation of the protein and use of an antibody reagent specific for binding a linear peptide epitope therein. Denaturation by chemical or physical means effectively exposes or enhances the exposure of the linear peptide epitope for binding by the antibody reagent which is preferably raised against a synthetic peptide immunogen. The technique is particularly useful in performing immunoassays for protein analytes such, as a glycosylated protein, in aqueous test samples. Monoclonal antibodies are also provided which are specific for the glucosylated N-terminal peptide sequence in the beta-subunit of human hemoglobin and are …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted July 14, 1998. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 14, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.